Navigation Links
Summer Street Research Partners Closes Financing for ImmunoCellular Therapeutics, Ltd.
Date:3/4/2011

BOSTON, March 4, 2011 /PRNewswire/ -- Summer Street Research Partners is pleased to announce the recent closing of a financing for ImmunoCellular Therapeutics, Ltd. (OTC Bulletin Board: IMUC), a Los Angeles-based clinical-stage company that is developing immune-based therapies for the treatment of brain and other cancers. The Company recently started a Phase II trial of its lead product candidate, ICT-107, a dendritic cell-based vaccine targeting multiple tumor associated antigens for newly diagnosed glioblastoma. ImmunoCellular raised approximately $8.1 million primarily from U.S. based institutional investors. Summer Street Research Partners served as the lead placement agent for the transaction.

"Summer Street Research is very excited to be involved with ImmunoCellular, an innovative company with some of the most compelling data seen to date in Glioblastoma.  We are delighted to assist them with this financing and the interest from high quality fundamental healthcare investors," said Al Sollami, CEO of Summer Street Research Partners.

Summer Street Research Partners is an investment banking, institutional equity research and trading firm that focuses exclusively on the healthcare sector. Our mission is to help our clients maximize returns by providing the best healthcare research, ideas and investment opportunities. The firm was founded in 2002, with a culture of providing a proprietary equity research product, utilizing more than 10,000 physicians and industry professionals provided through MCRI, a division of Summer Street Research Partners. www.ssrp.com Contact: Nickolay V. Kukekov, Ph.D.Managing Director, Investment BankingSummer Street Research Partners(212)-209-3971 (o)nkukekov@ssrp.com
'/>"/>

SOURCE Summer Street Research Partners
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Expanded Lipoprotein Testing, VAP® Cholesterol Test Discussed at National Lipid Association Summer Clinical Lipid Update
2. Cellectis to Present at the FASEB Summer Research Conference on Genome Engineering
3. Health Robotics and McKesson to Showcase i.v.STATION and i.v.SOFT at ASHPs Summer Meeting, Tampa, June 6-8, 2010
4. Summerhill Biomass Systems Unveils Solid Biomass Technology System at Syracuse Expo
5. ECBC Now Accepting Applications for 2009 Minority Undergraduate Summer Internship Program
6. LI-COR Updates Product and Application Guide for Summer 2008
7. NeoStem to Present at Wall Street Forum 2011 Financial Conference on Tuesday, March 1
8. Aethlon Medical to Present at the Wall Street Analyst Forum 22nd Annual Investor Conference
9. ClearTrial to Head Panel of Leading Wall Street Analysts at Pharmaceutical Accounting and Reporting Congress
10. Abbott Wins Top Honor in Wall Street Journal Technology Innovation Awards
11. SpectraCell Contracts With Beech Street Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... 2017  ArmaGen, Inc., today announced that it ... chief executive officer, as well as a member ... ArmaGen more than 17 years of executive management ... biotherapeutics and pharmaceuticals. "Mathias is ... and skillset necessary to lead ArmaGen to its ...
(Date:1/19/2017)... ... 2017 , ... The American Medical Informatics Association (AMIA) today ... Policy. Specifically, the nation’s leading informatics experts, said data sharing plans should be ... recommended that NIH earmark funding for researchers to produce and execute data sharing ...
(Date:1/19/2017)... ... 19, 2017 , ... FireflySci Inc. is a go-getter type of company that ... accounted to two main factors. The first is the amazing customer service that ... FireflySci products all around the world. , 2016 was a tremendous sales year for ...
(Date:1/19/2017)... , Jan. 18, 2017 The global ... USD 92.9 billion by 2025, according to a ... industry has been adaptive of the function of ... as 2002. Among the services outsourced, clinical trial ... instance, Johnson & Johnson was the first pharmaceutical ...
Breaking Biology Technology:
(Date:1/12/2017)... , January 12, 2017 A new report by Allied Market ... the global biometric technology market is expected to generate revenue of $10.72 billion by ... Continue Reading ... Allied Market Research Logo ...      (Logo: http://photos.prnewswire.com/prnh/20140911/647229) ...
(Date:1/6/2017)... , Jan. 6, 2017  Privately-held CalciMedica, ... studies in healthy volunteers of a novel calcium ... treat acute pancreatitis. Acute pancreatitis, ... a mild disorder, but can be very serious.  In ... and sepsis, where extended hospital stays, time in ...
(Date:1/4/2017)... 2017  For the thousands of attendees at this year,s International Consumer ... health and biometric measurement devices and services, will be featuring its new ... in A&D Medical,s special CES Exhibit Suite , the new upper ... the company,s WellnessConnected product platform.  ... ...
Breaking Biology News(10 mins):